Anavex Life Sciences Corp (AVXL)

[lt2211]

Every thing AF says below, is basically true. The results produced by AVXL, to this point, can not be trusted, without much further confirmation. He is not involved in some vast conspiracy to short the stock, just speaking the truth.

Bad clinical trials produce bad data, and Anavex is conducting a garbage study.

The only way to produce credible data in Alzheimer's is to conduct randomized, double-blind, placebo-controlled studies. One group of patients is randomized to receive a drug, the other group of patients received a placebo. Neither the patients nor their doctors know which arm of the study they're in. These studies need to run for at least one year because it takes that long to detect meaningful changes in memory, cognition and functions of daily living of patients.